Tag: Christopher Porter
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Featured Article
How Taiwan is revolutionising its AI data centres with liquid cooling
The rapid advancement of artificial intelligence relies heavily on the infrastructure that supports it. As AI continues to transform industries worldwide, the demand for robust and efficient data centre operations has never been more critical. This, in turn, has brought attention to the environmental impact of these facilities.
